Form4insider filings, from the source

SEC Form 4 · accession 0001106578-26-000104

UNITED THERAPEUTICS Corp · UTHR

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Martine A Rothblatt
Officer — Chairperson & CEO · Director
Period of report
Jul 22, 2026
Accepted (ET)
Jul 23, 2026 · 4:36 pm EDT
Rule 10b5-1 plan
yes — trade under a plan
Issuer CIK
0001082554

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF2Jul 22, 2026M9,500$135.42A333,943Iby Trust
Common StockF3,F2Jul 22, 2026S120$524.27D333,823Iby Trust
Common StockF4,F2Jul 22, 2026S485$526.0432D333,338Iby Trust
Common StockF5,F2Jul 22, 2026S2,610$526.8421D330,728Iby Trust
Common StockF6,F2Jul 22, 2026S1,211$527.819D329,517Iby Trust
Common StockF7,F2Jul 22, 2026S874$528.9072D328,643Iby Trust
Common StockF8,F2Jul 22, 2026S760$529.7954D327,883Iby Trust
Common StockF9,F2Jul 22, 2026S400$531.2245D327,483Iby Trust
Common StockF10,F2Jul 22, 2026S489$533.2424D326,994Iby Trust
Common StockF11,F2Jul 22, 2026S324$534.185D326,670Iby Trust
Common StockF12,F2Jul 22, 2026S107$535.4025D326,563Iby Trust
Common StockF13,F2Jul 22, 2026S790$536.4894D325,773Iby Trust
Common StockF14,F2Jul 22, 2026S570$537.6034D325,203Iby Trust
Common StockF15,F2Jul 22, 2026S680$538.4603D324,523Iby Trust
Common StockF16,F2Jul 22, 2026S80$539.47D324,443Iby Trust
Common Stockholding———40,513D
Common Stockholding———166Iby Spouse
Common StockF17holding———249,108Iby Trust
Common StockF18holding———45,596Iby Trust
Common StockF19holding———89,002Iby Trust

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Stock OptionF20$135.42Jul 22, 2026M9,500DMar 15, 2023Mar 15, 2027Common Stock9,500293,910I

Explanation of responses